CAS 1219802-60-4

Fórmula: C24H35Cl2N3O4

InChI: InChI=1S/C24H33N3O4.2ClH/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3;;/h4-10,20,28H,11-17H2,1-3H3,(H,25,29);2*1H/i11D2,12D2,13D2,14D2;;

Clave InChI: RJNSNFZXAZXOFX-ZWKVGDSCSA-N

SMILES: [2H]C1(C(N(C(C(N1CC(COC2=CC=CC=C2OC)O)([2H])[2H])([2H])[2H])CC(=O)NC3=C(C=CC=C3C)C)([2H])[2H])[2H].Cl.Cl

Ranolazine-d8 (dihydrochloride)

CAS: 1219802-60-4

Ranolazine-d8 (dihydrochloride)

Fórmula: C₂₄H₂₇Cl₂D₈N₃O₄

Pureza: 99%

Peso molecular: 508.51

Ref: 54-DE3340

(±)-Ranolazine-d8 2HCl(piperazine-d8)

CAS: 1219802-60-4, 95635-56-6

Pureza: 98 atom % D

Forma y color: White Solid

Peso molecular: 508.51

Ref: 3U-D7014

Ranolazine-d8 dihydrochloride

CAS: 1219802-60-4

Ranolazine-d8 dihydrochloride is a drug product that has been approved for the treatment of angina pectoris. Ranolazine is a drug that belongs to the class of antianginal drugs. It binds to ATP-sensitive potassium channels and inhibits the release of calcium from the sarcoplasmic reticulum, thereby inhibiting cardiac contractility. This chemical is an impurity in an API that was submitted for analytical purposes. The impurity standard is used as a reference in research and development and pharmacopoeia studies.

Fórmula: C₂₄H₃₅Cl₂N₃O₄

Pureza: Min. 95%

Peso molecular: 508.50 g/mol

Ref: 3D-UYB80260

Ranolazine-d8 Dihydrochloride

Producto controlado

CAS: 1219802-60-4

Fórmula: C₂₄D₈H₂₅N₃O₄·2ClH

Forma y color: Neat

Peso molecular: 508.508

Ref: TR-R122509